Panome Bio Launches Exposomics Services to Measure the Chemical Drivers of Human Disease
Newswise — ST. LOUIS, March 5, 2026 -- Panome Bio, a leading multi-omics contract research organization, today announced the launch of its exposomics platform, the first commercially available services that deliver comprehensive, unbiased chemical exposure …